Rilmazolam
Jump to navigation
Jump to search
Clinical data | |
---|---|
Trade names | (none, active metabolite of Rilmazafone) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
3D model (JSmol) | |
| |
|
Rilmazolam, is a benzodiazepine derivative which acts as a sedative and hypnotic drug, and the active metabolite of the drug Rilmazafone.[1] It has never been developed for medical uses, yet the aforementioned prodrug is an approved medication in Japan.
See also
References
- ^ Koike M, Norikura R, Sugeno K (March 1986). "Intestinal activation of a new sleep inducer 450191-S, a 1H-1,2,4-triazolyl benzophenone derivative, in rats". Journal of Pharmacobio-Dynamics. 9 (3): 315–20. doi:10.1248/bpb1978.9.315. PMID 3454653.
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs with non-standard legal status
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- GABAA receptor positive allosteric modulators
- Triazolobenzodiazepines
- All stub articles
- Nervous system drug stubs